Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevel Collect Regulatory News (RBG)

  • There is currently no data for RBG

Interim Management Statement

28 Jan 2010 07:00

RNS Number : 2136G
Rensburg Sheppards plc
28 January 2010
 

Rensburg Sheppards plc

Interim Management Statement 

28 January 2010

Rensburg Sheppards plc, the investment management group, today  publishes its Interim  Management Statement for the period from 1 October 2009 to 27 January 2010, which includes information on revenues and funds under management for the three months and nine months ended 31 December 2009.

Highlights - three months ended 31 December 2009:

·; Investment management fees and commissions up 21.4% and 27.1% respectively.
·; Investment management net revenue up 3.4%, despite a 71.8% decline in interest from client deposits.
·; Fund management net revenue up 4.5%.
·; Total net revenue up 3.5%.
·; Total funds under management up 1.5% to £12.31bn since 30 September 2009.
·; Disposal of Mayflower completed, generating a profit on disposal of £1.9m.

Steve Elliott, Chief Executive of Rensburg Sheppards, commented:

"Rensburg Sheppards continues to be soundly financed and cash generative. Whilst markets in the first few weeks of 2010 have remained uncertain, we believe that the strong base from which Rensburg Sheppards operates leaves the group well placed for the future". 

During the third quarter of the group's financial year there was further improvement in Rensburg Sheppards' operating environment, with equity markets continuing their recovery.

This improvement in the operating environment has been reflected in the revenue figures below, which show encouraging increases in the key revenue streams of fees and commissions over the last quarter and, for the investment management segment, for the financial year to date. As previously highlighted, interest from client deposits has continued to be depressed as the UK bank base rate has remained throughout the quarter at the historically low level of 0.5%. 

 

 
Three months ended
31 Dec 2009
£’000
Three months ended
31 Dec 2008
£’000
 
 
 
 
Change %
Nine months ended
31 Dec
2009
£’000
Nine months ended
31 Dec
2008
£’000
 
 
 
 
Change
%
 
 
 
 
 
 
 
Investment management:
 
 
 
 
 
 
- Fees
14,542
11,983
+21.4
41,248
38,579
+6.9
- Commissions
6,617
5,207
+27.1
18,176
16,255
+11.8
- Interest from client deposits
1,342
4,752
-71.8
5,144
12,341
-58.3
- Trail commission
1,337
1,396
-4.2
3,584
4,240
-15.5
- Other income
1,734
1,384
+25.3
4,864
5,226
-6.9
Sub-total
25,572
24,722
+3.4
73,016
76,641
-4.7
 
 
 
 
 
 
 
Fund management:
 
 
 
 
 
 
- Fees
2,088
2,010
+3.9
5,615
6,991
-19.7
- Profit on sale of units of unit trusts
 
324
 
280
 
+15.7
 
956
 
904
 
+5.8
- Other income
1
19
-94.7
17
35
-51.4
Sub-total
2,413
2,309
+4.5
6,588
7,930
-16.9
 
 
 
 
 
 
 
Total net revenue*
27,985
27,031
+3.5
79,604
84,571
-5.9
 
 
 
 
 
 
 

 

Net of fees and commissions payable to introducers. Net revenue does not include income or profit relating to the disposal of Mayflower or the Corporate Bond Trust, which was disposed of during the six months ended 30 September 2009. 

The investment management segment's funds under management below reflect the impact of the disposal on 30 December 2009 of Mayflower Management Company Limited ('Mayflower'), a wholly owned group company. Mayflower's sole activity was to manage a charity property fund which, at disposal, had discretionary assets under management of £299 million. This disposal was completed for a cash consideration of £1.9 million plus the negligible net assets of Mayflower. The ensuing profit on disposal of £1.9 million is anticipated to be free of corporation tax.

The discretionary funds managed by Mayflower formed part of the investment management segment and were relatively low-yielding for the business. Despite the outflow of these funds, the group's total funds under management during the three months ended 31 December 2009 increased by 1.5%, compared with increases of 2.5% and 4.8% in the FTSE APCIMS Private Investors Balanced and FTSE All-Share indices respectively. 

An analysiof the group's funds under management by business segment is given below:

 
31 Dec 2009
£bn
 
 30 Sept 2009
£bn 
Change since 30 Sept 2009
%
31 Mar 2009
£bn
 
 
 
 
 
Investment management:
11.03
10.85
+1.7
8.93
- Discretionary
8.08
7.93
+1.9
6.46
- Non-discretionary
2.95
2.92
+1.0
2.47
 
 
 
 
 
Fund management:
1.28
1.28
+0.0
1.08
- Retail units
0.92
0.89
+3.4
0.77
- Segregated mandate
0.36
0.39
-7.7
0.31
 
 
 
 
 
Total funds under management
12.31
12.13
+1.5
10.01
 
 
 
 
 
 
 
 
 
 
FTSE APCIMS Balanced
2,724.3
2,658.0
+2.5
2,230.5
FTSE All-Share
2,760.8
2,634.8
+4.8
1,984.2

 

As announced previously on 18 November 2009, we welcomed three new executive directors to the board with their appointments being effective from 1 December 2009. In addition, the team of eight investment managers who joined our Edinburgh office in mid-November 2009 have settled in well and we are pleased with their progress to date in signing up clients.

Rensburg Sheppards continues to be soundly financed and cash generative. Cash and cash equivalents less subordinated debt totalled £44.0 million as at 31 December 2009. Whilst markets in the first few weeks of 2010 have remained uncertainwe believe that the strong base from which Rensburg Sheppards operates leaves the group well placed for the future. 

For further information, please contact:

Steve Elliott, Chief Executive Tel: 020 7597 1234

Jonathan Wragg, Finance Director Tel: 0114 228 6705

Rensburg Sheppards plc

Nick Lyon / Michael Sandler Tel: 020 7796 4133

Hudson Sandler

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBXGDBUSDBGGR
Date   Source Headline
25th Sep 201912:40 pmRNSHolding(s) in Company
10th Sep 20194:32 pmRNSNotice of Results
10th Sep 20199:50 amRNSHolding(s) in Company
4th Jul 201910:50 amRNSHolding(s) in Company
3rd Jul 20195:05 pmRNSHolding(s) in Company
28th Jun 20192:09 pmRNSHolding(s) in Company
5th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20197:00 amRNSDirector/PDMR Shareholding
14th Mar 20194:05 pmRNSHolding(s) in Company
1st Mar 20197:00 amRNSInterim Results
1st Feb 201910:40 amRNSAppointment of Brokers
15th Jan 201911:00 amRNSHolding(s) in Company
14th Jan 20192:50 pmRNSHolding(s) in Company
14th Jan 20197:00 amRNSTrading Update
3rd Jan 20192:38 pmRNSNotice of Reporting Dates
21st Dec 201810:49 amRNSDirector Declaration
19th Dec 20183:07 pmRNSHolding(s) in Company
18th Dec 20184:41 pmRNSSecond Price Monitoring Extn
18th Dec 20184:35 pmRNSPrice Monitoring Extension
18th Dec 20184:00 pmRNSIndependent Auditor's Report - Correction
4th Dec 20187:01 amRNSPrice Monitoring Extension
3rd Dec 20184:35 pmRNSPrice Monitoring Extension
27th Nov 20188:30 amRNSDirector Declaration
26th Nov 201812:45 pmRNSResult of AGM
22nd Oct 20184:15 pmRNSAnnual Report and Notice of AGM
22nd Oct 20184:15 pmRNSMatters relating to previous distributions
19th Oct 201811:30 amRNSGrant of Options
17th Oct 20185:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:16 pmRNSHolding(s) in Company
15th Oct 201811:58 amRNSHolding(s) in Company
10th Oct 20185:15 pmRNSTermination of discussions
10th Oct 201810:34 amRNSAppointment of Non-Executive Director
8th Oct 20184:15 pmRNSTotal Voting Rights
8th Oct 20189:14 amRNSHolding(s) in Company
2nd Oct 201811:15 amRNSDividend Record Date
2nd Oct 20187:00 amRNSPreliminary Results
26th Sep 201810:30 amRNSHolding(s) in Company
20th Sep 20184:00 pmRNSNotice of Preliminary Results
13th Sep 20182:22 pmRNSHolding(s) in Company
10th Sep 20184:48 pmRNSHolding(s) in Company
7th Sep 20185:56 pmRNSStatement re Press Comment
22nd Aug 20187:11 amRNSDirector Declaration
14th Aug 20182:54 pmRNSHolding(s) in Company
14th Jun 20187:00 amRNSTrading Update
12th Jun 201812:55 pmRNSHolding(s) in Company
8th Jun 20185:15 pmRNSHolding(s) in Company
23rd May 20188:48 amRNSHolding(s) in Company
20th Apr 20187:00 amRNSCEO starting date
12th Apr 20185:48 pmRNSDirector/PDMR Shareholding
2nd Mar 20187:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.